 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Section 1: Fundamentals of the Identification Threshold

Topic: Identification Threshold Concept and Application

The Ground Truth (for Trainer Reference — Attachment 1)

Slide 2 — Concept Simplified (60 sec)

Section 2: Workflows, Case Studies, and Compliance

Slide 4 — Practical Application (60 sec)

Slide 3 — Case Study (90 sec)

  Audit / Inspection-Readiness Checklist

Section 3: Quiz Assessment

MCQ 1. What action does crossing the identification threshold specifically require?

MCQ 2. A drug substance has a maximum daily dose of 1.5 g/day. An unknown impurity is at 0.09%. Is identification required?

MCQ 3. Which ICH guideline applies to the identification threshold for impurities in a chemically synthesised drug substance (API)?

MCQ 4. An impurity at 0.06% in a drug dosed at 400 mg/day is found to be DNA-reactive (mutagenic). What is the correct basis for control?

MCQ 5. For a drug substance dosed at 3 g/day, what is the identification threshold?

Section 4: Course Evaluation and Feedback

Part B — Reflection

Course Feedback Survey

Welcome to "Applying Impurity Identification Thresholds According to ICH Q3A(R2)," a comprehensive online course designed for pharmaceutical professionals, quality assurance experts, and analytical chemists. Ensuring patient safety and product quality is paramount in pharmaceutical development, and a critical component of this is the accurate identification and control of impurities in chemically synthesized new drug substances.

Welcome to "Applying Impurity Identification Thresholds According to ICH Q3A(R2)," a comprehensive online course designed for pharmaceutical professionals, quality assurance experts, and analytical chemists. Ensuring patient safety and product quality is paramount in pharmaceutical development, and a critical component of this is the accurate identification and control of impurities in chemically synthesized new drug substances. This course provides an in-depth exploration of the ICH Q3A(R2) guidelines, focusing specifically on the identification threshold.

Throughout this training, you will learn how to distinguish the identification threshold from reporting and qualification thresholds, and understand the scientific rationale behind triggering structural identification. We will guide you through practical workflows to quantify impurities, convert them against maximum daily doses, and evaluate them using the dual criterion of percentage versus the 1.0 mg/day absolute intake cap.

Beyond the fundamentals, this course dives into real-world case studies, borderline compliance scenarios, and the intersection of ICH Q3A(R2) with ICH M7 for mutagenic impurities. You will also gain access to a robust 10-Point Audit and Inspection-Readiness Checklist to ensure your analytical methods and documentation practices meet stringent regulatory expectations. Whether you are preparing for a regulatory submission or looking to strengthen your quality control processes, this course equips you with the knowledge and tools to make risk-based compliance decisions confidently. Enroll today to master impurity profiling and safeguard your pharmaceutical products.

103. Applying Impurity Identification Thresholds According to ICH Q3A(R2)

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The control of impurities in chemically synthesized new drug substances is a fundamental pillar of pharmaceutical quality assurance and regulatory compliance. According to the ICH Q3A(R2) guideline, establishing precise identification thresholds is imperative to ensure patient safety and product efficacy. This course provides a comprehensive examination of these thresholds, clearly distinguishing them from reporting and qualification limits. It is specifically designed for quality assurance (QA), quality control (QC), regulatory affairs, and manufacturing professionals who are responsible for reviewing impurity data, setting specifications, and authoring Module 3 (3.2.S.3.2) documentation. By focusing strictly on chemically synthesized active pharmaceutical ingredients (APIs), the curriculum addresses the distinct analytical and regulatory challenges inherent in impurity profiling, explicitly excluding out-of-scope areas such as biologics, herbal products, and finished-product degradation.</p>

<p>Throughout this program, participants will systematically navigate the foundational concepts and practical applications of impurity identification. The curriculum begins with an in-depth analysis of the identification threshold concept, including the critical dual criterion of percentage limits versus the 1.0 mg/day absolute intake cap based on maximum daily dose. Subsequent modules transition into practical workflows, offering complex case studies and a rigorous 10-point audit-readiness checklist to facilitate risk-based compliance decisions. Professionals will learn to accurately calculate exposure levels, evaluate borderline scenarios, and recognize when alternative guidelines, such as ICH M7 for mutagenic impurities, must take precedence. Ultimately, this training equips analytical reviewers and regulatory authors with the robust methodological framework required to maintain inspection readiness and uphold the highest standards of pharmaceutical integrity.</p>
        </div>
    </div>
</div>
